Just saw a tweet from June 18th on RVX Investor page
https://twitter.com/biotechnation
Moira Gunn (@biotechnation): "Donald McCaffrey in the studio on an epigenetic therapy for patients with both cardiovascular disease and diabetes @Resverlogix_RVX #BIO2015"
Wonder if anything will come of that?